CN102475880A - Qi-benefiting and blood-nourishing tablets - Google Patents
Qi-benefiting and blood-nourishing tablets Download PDFInfo
- Publication number
- CN102475880A CN102475880A CN2010105733636A CN201010573363A CN102475880A CN 102475880 A CN102475880 A CN 102475880A CN 2010105733636 A CN2010105733636 A CN 2010105733636A CN 201010573363 A CN201010573363 A CN 201010573363A CN 102475880 A CN102475880 A CN 102475880A
- Authority
- CN
- China
- Prior art keywords
- blood
- benefiting
- aplastic anemia
- tablets
- nourishing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to qi-benefiting and blood-nourishing tablets, which are current novel products specially used for treating aplastic anemia. Aplastic anemia is a disease caused by gradually exhausted or partially stagnated bone marrow hematopoietic function. Aplastic anemia has a main clinical manifestation of pancytopenia. There are many causes for the disease, and qi asthenia and blood deficiency is one of the causes. The tablets are prepared from Mongolian milkvetch root, pilose asiabell root, ligusticum, largehead atractylodes rhizome, Indian bread with hostwood, spine date seed, common yam rhizome, and ginger. The tablets provide functions of qi benefiting, blood nourishing, kidney enhancing, and vital genetic energy preserving. The tablets provide substantial treatment effects for aplastic anemia patients.
Description
A kind of benefiting QI and nourishing blood sheet is the last word of inventing at present of specially controlling aplastic anemia.
Aplastic anemia is that progressively depleted or part is stagnated by the bone marrow hematogenesis function, caused a kind of be the disease of main clinical manifestation with the pancytopenia.
Primary disease divides two types of constitutional and Secondary cases, and wherein constitutional accounts for the overwhelming majority, etiology unknown, and the Secondary cases cause of disease has following 4 points:
(1) chemical factor benzene, organo-arsenic, golden preparation and sulfa drugs, antitumor drug, antiepileptic, some antibiotic medicine etc.
(2) physical factor radiosiotope, lonizing radiation, radium ingot etc.
(3) serious bacterial infection or viral infection is like typhoid fever, phthisis miliaris, infectious hepatitis etc.
(4) late period of some disease of other diseases is like chronic renal failure etc.
Primary disease divides acute and chronic two types clinically:
Acute is a main feature with visceral hemorrhage and severe infections, majority threat to life in the several months.
The chronic type onset is slow, and the course of disease is very long, and is hemorrhage with anemia, infects the main performance for this type.
The lab testing surrounding hemogram is in model case, and erythrocyte, leukocyte, platelet all reduce.For very, reticulocyte counts lowers acute, is everlasting below 1% with neutrophilic granulocyte and thrombocytopenia.Chronic type is except that platelet, and other compositions are all high than acute, and reticulocyte is sometimes more than 1%.
Bone marrow smear: the nucleated cell sum significantly reduces, and normoblast, myelocyte, megalokaryocyte all obviously reduce, even lacks, and lymphocyte increases relatively.Plasma cell, organize basophil and skein cell to increase.
Aplastic anemia meets the category of motherland's medical science " asthenia exhaustion of blood ", " deficient ", " blood disorder " basically.Motherland's medical science thinks that primary disease is because natural endowment is not enough, or the day after tomorrow, improper diet and overtiredness was improper, or prolonged illness causes the energy and blood of human body loss, is difficult for the disease of recovering for a long time.
The object of the invention is invented a kind of new drug exactly and is prevented and treated, the generation of aplastic anemia.
Formula material, prescription ratio, formulation principle, method for preparing
Formula material, prescription ratio: Radix Astragali 100g, Radix Codonopsis 100g, Radix Angelicae Sinensis 75g, Rhizoma Atractylodis Macrocephalae 75g,
Poria cum Radix Pini 200g, Semen Ziziphi Spinosae 100g, Rhizoma Dioscoreae 100g, Rhizoma Zingiberis Recens 30g
Formulation principle: the Radix Astragali---sweet in the mouth slightly warm in nature can help defends gas-solid skin table, the lucid yang sending up gas, invigorating middle warmer gas.
Radix Codonopsis---nature and flavor are sweet flat, and main function can air making-up and spleen enlivening.
Radix Angelicae Sinensis---the little hardship of acrid-sweet flavor, warm in nature is the main medicine of controlling blood system.
The Rhizoma Atractylodis Macrocephalae---sweet-bitter flavor, slightly warm in nature, the function the spleen strengthening and damp drying, QI invigorating and blood producing with in antiabortive.
Poria cum Radix Pini---slightly sweet flavor property is flat, and main function has three (1) diuretic to remove the hemostasis of temperature (2) mind tranquilizing and the heart calming (3) strengthening the spleen.
Semen Ziziphi Spinosae---main effect, mind tranquilizing and the heart calming arresting sweating.
Rhizoma Dioscoreae---sweet in the mouth is warm in nature, function strengthening the spleen stomach, tonifying the lung gas kidney tonifying controlling nocturnal emission with astringent drugs.
Rhizoma Zingiberis Recens---acrid in the mouth slightly warm in nature, function relieving the exterior syndrome by diaphoresis, dispersing wind-cold.
Method for preparing: above eight kinds of Chinese herbal medicine are pulverized with Chinese medicine grinder, got 100 order medicated powder and mixing thoroughly with binding agent, mix, humidity is moderate, and the reuse pelleter is processed small pieces, drying and packaging qualified products.
Claims (3)
1. benefiting QI and nourishing blood sheet is characterized in that:
1. this product is to be formed by eight flavor prepared from traditional Chinese medicines such as the Radix Astragali, Radix Codonopsis.
2. this product can benefiting QI and nourishing blood, the kidney tonifying controlling nocturnal emission with astringent drugs.
2. 1. said according to claim, this product is to be formed by eight kinds of prepared from traditional Chinese medicines such as the Radix Astragali, Radix Codonopsis.
3. 2. said according to claim, this product is owing to ability benefiting QI and nourishing blood, kidney tonifying controlling nocturnal emission with astringent drugs.So the aplastic anemia that Qi and blood deficiency is caused has remarkable therapeutic effect.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105733636A CN102475880A (en) | 2010-11-27 | 2010-11-27 | Qi-benefiting and blood-nourishing tablets |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105733636A CN102475880A (en) | 2010-11-27 | 2010-11-27 | Qi-benefiting and blood-nourishing tablets |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN102475880A true CN102475880A (en) | 2012-05-30 |
Family
ID=46088738
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105733636A Pending CN102475880A (en) | 2010-11-27 | 2010-11-27 | Qi-benefiting and blood-nourishing tablets |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102475880A (en) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103300114A (en) * | 2013-06-27 | 2013-09-18 | 叶建斌 | Qi benefiting and blood nourishing healthy food and preparation method thereof |
-
2010
- 2010-11-27 CN CN2010105733636A patent/CN102475880A/en active Pending
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103300114A (en) * | 2013-06-27 | 2013-09-18 | 叶建斌 | Qi benefiting and blood nourishing healthy food and preparation method thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN106390013A (en) | Compound traditional Chinese medicine composition capable of inhibiting colorectal liver metastases as well as preparation method and application thereof | |
| CN102961636B (en) | Pure traditional Chinese medicine composition for treating poultry infectious bursal disease and preparation method thereof | |
| CN101249243B (en) | Chinese medicine for curing acute leukemia | |
| CN101062339A (en) | Medicine for treating diabetes | |
| CN101856487A (en) | Chinese medicament for treating insomnia | |
| CN102475880A (en) | Qi-benefiting and blood-nourishing tablets | |
| CN102793896A (en) | Membranous milkvetch root and pilose Asiabell root tablet | |
| TWI646964B (en) | Pharmaceutical composition, preparation method and use thereof for reducing side effects of cancer treatment drugs | |
| CN112891485B (en) | Traditional Chinese medicine composition for treating neocoronary pneumonia | |
| CN104225163A (en) | Drug composition for treating aplastic anemia and preparation method and application thereof | |
| CN1162172C (en) | Baixue-Genzhi-Changshoubao-Chinese medicine for treating leukemia and concurrently treating aplastic anemia | |
| CN102772749A (en) | Fushen-wild jujube tablets | |
| CN102475825A (en) | Spleen-tonifying and blood-enriching pill | |
| Li et al. | Effects of traditional Chinese herbal medicines on blood cell count and immunity in chickens | |
| CN106728579A (en) | A kind of Chinese medicine composition for treating piglet epidemic diarrhea | |
| CN102784315A (en) | Chinese patent medicine for treating chronic myeloid leukemia | |
| CN101642485B (en) | Application of medical composition containing astragalus root in preparing medicine for treating leucopenia and Henoch-Schonlein Purpura | |
| CN104758485A (en) | Traditional Chinese medicine composition for treating aplastic anemia and preparation method of traditional Chinese medicine composition | |
| CN102366537A (en) | Traditional Chinese medicine preparation for treating cough caused by lung dryness and preparation method thereof | |
| CN103120773A (en) | Medicinal composition for treating mycoplasma pneumonia in children | |
| CN103768519B (en) | A kind of compound medicine improving cyclophosphamide antitumor curative effect and preparation method thereof | |
| CN102475807A (en) | Tablets used for controlling anemia | |
| CN101829213B (en) | Medicine composition for treating asthma and preparation method thereof | |
| CN108635498B (en) | Pharmaceutical composition for treating myelodysplastic syndrome and application thereof | |
| CN102772584A (en) | Folium isatidis-Chinese angelica tablets |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20120530 |